n | 5 y OS (%) | P value | 5 yr LSS (%) | P value | 5 y DFS (%) | P value | 5 yr LC (%) | P value | |
---|---|---|---|---|---|---|---|---|---|
All patients | 84 | 53 | 59 | 41 | 87 | ||||
Age (yrs) | |||||||||
• <64 | 42 | 60 | 0.07 | 67 | NS | 45 | NS | 92 | NS |
• >64 | 42 | 44 | 49 | 38 | 82 | ||||
Stage | |||||||||
• I E | 46 | 62 | 0.007 | 70 | 0.006 | 52 | 0.05 | 92 | 0.05 |
• II E | 33 | 40 | 44 | 28 | 81 | ||||
Grade | |||||||||
• High | 51 | 42 | NS | 50 | NS | 36 | NS | 85 | NS |
• Low/intermediate | 33 | 66 | 70 | 48 | 90 | ||||
Tumor size | |||||||||
• < 4 cm | 38 | 58 | NS | 68 | NS | 40 | NS | 91 | NS |
• > 4 cm | 33 | 43 | 44 | 43 | 83 | ||||
Surgery | |||||||||
• C.S. | 63 | 62 | 0.03 | 69 | 0.01 | 48 | NS | 91 | NS |
• Mastectomy | 21 | 22 | 26 | 18 | 78 | ||||
RT | |||||||||
• Yes | 51 | 58 | NS | 70 | 0.02 | 41 | NS | 95 | 0.005 |
• No | 33 | 46 | 46 | 40 | 76 | ||||
Chemotherapy | |||||||||
• Yes | 59 | 47 | NS | 51 | NS | 39 | NS | 92 | NS |
• No | 25 | 61 | 72 | 44 | 77 | ||||
Combined modality | |||||||||
• Yes | 37 | 54 | NS | 64 | NS | 37 | NS | 96 | 0.03 |
• no | 47 | 51 | 56 | 43 | 81 |